Haemonetics Corp. (HAE) Misses Q2 EPS Views; Guides Soft FY11 EPS
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $72.87 --0%
EPS Growth %: -0.9%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -0.9%
Financial Fact:
Selling, general and administrative: 71.12M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Haemonetics Corp. (NYSE: HAE) reported Q2 EPS of $0.72, $0.76 worse than the analyst estimate of $0.76. Revenue for the quarter came in at $179.4 million versus the consensus estimate of $173.55 million.
Haemonetics Corp. sees FY2011 EPS of $3.00-$3.10, versus the consensus of $3.38.
Haemonetics Corp. sees FY2011 EPS of $3.00-$3.10, versus the consensus of $3.38.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q4 EPS by 4c
- Crown Crafts (CRWS) Reports Q4 EPS of $0.03
- Paychex beats fourth quarter EPS estimates, stock slides
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
